It describes a timeline where symptoms peak three to six weeks after starting or increasing treatment, stabilize through weeks six to twelve, then gradually improve as metabolic adaptation completes
Clinical trials have shown remarkable results, with participants experiencing substantial reductions in body weight
Genetic Testing and Personalized GLP-1 Pathway Insight PlexusDx's Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes to reveal your predisposition in GLP-1 and metabolic pathways
This dual mechanism may offer enhanced effects on weight reduction and metabolic control compared to GLP-1 agonists alone
Additionally, staying hydrated by drinking plenty of water can help alleviate stomach discomfort
Patients prescribed weight loss medications often have multiple cardiovascular and metabolic risk factors that independently increase NAION risk, including diabetes, hypertension, hyperlipidemia, and obstructive sleep apnea